Search research articles
Contact Us
Filters
Showing results (411-420 of 471) with videos related to
Page
of 48
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2011
Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma
Kate H Brettingham-Moore, Cuong P Duong, Danielle M Greenawalt, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
June 8, 2023
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial
Samuel Tremblay, Mofarej Alhogbani, Andrew Weickhardt, et al.
International Journal of Cancer
|
September 12, 2019
Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals
Simone Leyden, Teodora Kolarova, Catherine Bouvier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2014
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
The Lancet. Haematology
|
December 22, 2015
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
Colm Keane, Frank Vari, Mark Hertzberg, et al.
The New England Journal of Medicine
|
March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
Constantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
International Journal of Cancer
|
December 16, 2017
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance
Claire A Martin, Carleen Cullinane, Laura Kirby, et al.
Journal of Neuroendocrinology
|
October 20, 2021
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours
Rodney J Hicks, Clarisse Dromain, Wouter W de Herder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2023
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
Lavinia Tan, Ben Tran, Jeanne Tie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2015
Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al
Sally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
Page
of 48
Search research articles
Search
Showing results (411-420 of 471) with videos related to
Sort By:
Page
of 48
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2011
Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma
Kate H Brettingham-Moore, Cuong P Duong, Danielle M Greenawalt, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
June 8, 2023
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial
Samuel Tremblay, Mofarej Alhogbani, Andrew Weickhardt, et al.
International Journal of Cancer
|
September 12, 2019
Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals
Simone Leyden, Teodora Kolarova, Catherine Bouvier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2014
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
The Lancet. Haematology
|
December 22, 2015
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
Colm Keane, Frank Vari, Mark Hertzberg, et al.
The New England Journal of Medicine
|
March 29, 2018
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
Constantine S Tam, Mary Ann Anderson, Christiane Pott, et al.
International Journal of Cancer
|
December 16, 2017
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance
Claire A Martin, Carleen Cullinane, Laura Kirby, et al.
Journal of Neuroendocrinology
|
October 20, 2021
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours
Rodney J Hicks, Clarisse Dromain, Wouter W de Herder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2023
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
Lavinia Tan, Ben Tran, Jeanne Tie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2015
Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al
Sally F Barrington, N George Mikhaeel, Lale Kostakoglu, et al.
Page
of 48